Levi Strauss & Co (NYSE:LEVI). reported its fourth-quarter 2024 earnings, revealing a slight miss in earnings per share (EPS) compared to forecasts, while exceeding revenue expectations. The company's ...
Stifel analysts increased the price target on Nurix Therapeutics Inc . (NASDAQ:NRIX) shares to $36.00, up from the previous target of $34.00, while reaffirming their Buy rating on the stock. The ...